| abstract |
The present invention is directed to novel compounds that are thrombin inhibitors and are useful for the treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases. The compounds have general Formula (I), and parmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, n and m are defined herein. |